SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (301)5/21/1999 10:37:00 AM
From: sim1  Respond to of 3559
 
I wonder who's buying this morning. <eom>



To: Miljenko Zuanic who wrote (301)6/3/1999 1:01:00 AM
From: margie  Read Replies (1) | Respond to of 3559
 
next step? 1999 Meeting of the Institute of Human Virology will be held August 28-September 2, 1999 in Baltimore, Maryland.
ihv.org

Roy Vagelos, Regeneron Pharmaceuticals and Robert Gallo, Institute of Human Virology are the Chairpersons at a mini-session, Monday August 30th.
Emerging Technologies
Special Lecture by Maurice Hilleman, Merck
Twentieth Century Paradigms for Twenty-First Century Science

Interesting roster of speakers at this session:
ï‚· Antonin Scalia, Supreme Court of the United States
ï‚· *Bruce Alberts, National Academy of Sciences
ï‚· Anthony Fauci, NIAID/NIH
ï‚· R. Gordon Douglas, Merck & Co., Inc.
ï‚· Reinhard Kurth, Paul-Ehrlich-Institute
ï‚· Robert Gallo, Institute of Human Virology
ï‚· Hans Wigzell, Karolinska Institute
ï‚· Christopher Howson, The March of Dimes
ï‚· Geoffrey Schild, National Institute for Biological Standards and Control
ï‚· Fritz Melchers, Basel Institute for Immunology
ï‚· P. Roy Vagelos, Regeneron Pharmaceuticals